Evolution of patients with chronic hepatitis C infection with advanced fibrosis or cirrhosis cured with direct-acting antivirals. Long-term follow-up Ester Badia Aranda; Cristina Fernández Marcos; Aida Puebla Maestu; Visitación Gozalo Marín; Raquel Vinuesa Campo; Sara Calvo Simal; Judith Gómez Camarero;

Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction Javier Crespo; Joaquín Cabezas; Antonio Aguilera; Marina Berenguer; María Buti; Xavier Forns; Federico García; Javier García-Samaniego; Manuel Hernández-Guerra; Francisco Jorquera; Jeffrey V. Lazarus; Sabela Lens; Elisa Martró; Juan Antonio Pineda; Martín Prieto; Francisco Rodríguez-Frías; Manuel Rodríguez; Miguel Ángel Serra; Juan Turnes; Raquel Domínguez-Hernández; Miguel Ángel Casado; José Luis Calleja;

Non-pharmacologic direct cost of a simplified strategy with glecaprevir/pibrentasvir for 8 weeks in naïve non-cirrhotic patients with hepatitis C implemented in clinical practice. The Just SIMPLE Study Juan Turnes; Diego Rincón; José L. Calleja; Manuel B. Delgado; José M. Rosales; Raúl J. Andrade; María L. Manzano; Francisco J. Salmerón; María A. López; Marta Calvo; Judith Gómez; Esther Molina; Yza Nubia Frias; Roque Miguel Gálvez-Fernández; Nicolau Vallejo-Senra; Sara París; Regina Santos de Lamadrid; Antonio Olveira;